Why insider trading matters?

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

- Peter Lynch
Coherus BioSciences, Inc. (CHRS)
Sector: Healthcare; Industry: Biotechnology

Coherus BioSciences, Inc., a commercial-stage biotherapeutics company, focuses on the biosimilar market worldwide. It markets UDENYCA, a long-acting granulocyte-colony stimulating factor, which stimulates production of granulocytes in order to promote the body's ability to fight infections. The company sells UDENYCA in the United States. Coherus BioSciences, Inc. has collaboration and license agreements with Daiichi Sankyo Company, Limited; Baxalta Incorporated; Baxalta US Inc.; Baxalta GmbH; and Selexis SA.

CHRS Symbol Info by TradingView

Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-02-17 Anicetti Vincent R Chief Operating Officer Sell 2,488 $17.45 $43,418 Yes
2021-02-01 Viret Jean-Frederic Chief Financial Officer Sell 7,402 $21.55 $159,513 Yes
2021-01-25 Viret Jean-Frederic Chief Financial Officer Sell 46,144 $19.95 $920,736 Yes
2021-01-19 Anicetti Vincent R Chief Operating Officer Sell 2,500 $17.94 $44,852 Yes
2020-12-17 Anicetti Vincent R Chief Operating Officer Sell 2,500 $17.51 $43,780 Yes
2020-12-10 Vexler Vladimir Chief Scientific Officer Sell 67,138 $18.19 $1,221,150 Yes
2020-12-07 Anicetti Vincent R Chief Operating Officer Sell 8,791 $18.42 $161,896 Yes
2020-12-04 Anicetti Vincent R Chief Operating Officer Sell 98,756 $18.76 $1,852,773 Yes
2020-11-18 Anicetti Vincent R Chief Operating Officer Sell 22,770 $17.72 $403,510 Yes
2020-11-17 Viret Jean-Frederic Chief Financial Officer Sell 1,995 $17.49 $34,896 Yes
2020-10-19 Anicetti Vincent R Chief Operating Officer Sell 3,217 $17.89 $57,556 Yes
2020-10-14 Viret Jean-Frederic Chief Financial Officer Sell 6,144 $19.00 $116,736 No
2020-09-17 Anicetti Vincent R Chief Operating Officer Sell 5,000 $18.84 $94,216 Yes
2020-08-17 Anicetti Vincent R Chief Operating Officer Sell 5,000 $19.37 $96,851 Yes
2020-07-17 Anicetti Vincent R Chief Operating Officer Sell 15,000 $18.25 $273,687 Yes
2020-06-22 Szela Mary T Director Sell 54,997 $17.58 $966,759 Yes
2020-06-17 Anicetti Vincent R Chief Operating Officer Sell 2,500 $17.22 $43,050 Yes
2020-06-17 Wahlstrom Mats Director Sell 200,000 $17.15 $3,430,020 No
2020-05-20 Viret Jean-Frederic Chief Financial Officer Sell 1,278 $17.66 $22,569 No
2020-05-18 Anicetti Vincent R Chief Operating Officer Sell 3,093 $17.17 $53,107 Yes
2020-04-20 Anicetti Vincent R Chief Operating Officer Sell 10,150 $16.30 $165,400 Yes
2020-03-03 Wahlstrom Mats Director Sell 118,066 $20.12 $2,375,409 No
2020-02-19 Viret Jean-Frederic Chief Financial Officer Sell 3,159 $22.33 $70,552 Yes
2020-02-18 Anicetti Vincent R Chief Operating Officer Sell 10,000 $21.64 $216,390 Yes
2020-01-17 Anicetti Vincent R Chief Operating Officer Sell 10,000 $19.59 $195,930 Yes
2020-01-15 Viret Jean-Frederic Chief Financial Officer Sell 6,318 $19.85 $125,424 Yes
2019-12-16 Anicetti Vincent R Chief Operating Officer Sell 2,500 $18.69 $46,725 Yes
2019-11-21 Lanfear Dennis M President & CEO Sell 12,500 $18.56 $231,960 No
2019-11-20 Lanfear Dennis M President & CEO Sell 825,000 $18.00 $14,850,000 No
2019-11-20 Viret Jean-Frederic Chief Financial Officer Sell 3,159 $19.59 $61,872 Yes

Insider Smart

SIMON PROPERTY GROUP (SPG) - Bottom fishing the crash could be intimidating, but it can be easier if you know insiders are on your side. Aeppel Glyn, Director of SPG played safe and bought shares in May at $50, but it is not late at all, the stock is now $90.

Insider Smart

Celldex Therapeutics, Inc. (CLDX) - Multiple insiders including President, EVP, CEO, CSO and Directors bought shares on Jun.9th, first time since 2018, this was very convincing and we initiated a position. Stock soared from $3 to 9$ in 2 days, and the run is still going on.